Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Atrial FibrillationHeart Failure
Trial Locations (5)

4031

Universitätsspital Basel, Basel

23909

DRK Mölln-Ratzeburg, Ratzeburg

29549

Herz- und Gefäßzentrum Bad Bevensen, Bad Bevensen

44534

St. Marien-Hospital Lünen, Lünen

80636

Deutsches Herzzentrum München, München

All Listed Sponsors
collaborator

Clinical Trial Unit, University Hospital Basel, Switzerland

OTHER

lead

Biotronik SE & Co. KG

INDUSTRY

NCT01930695 - Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T | Biotech Hunter | Biotech Hunter